Bruce X. Ling, PHD

Assistant Profess
Stanford University
Palo Alto, California, United States

Disclosure information not submitted.

Presentation(s):

• 37 - A MULTI-CENTER, NON-INFERIORITY STUDY TO EVALUATE  THE EFFICACY OF ELIMINATION OF HIGH-DOSE ASPIRIN IN THE ACUTE STAGE OF KAWASAKI DISEASE FOR PREVENTING CORONARY ARTERY LESIONS (KIAA TRIAL)

  Monday, August 26, 2024
  3:15 PM – 4:00 PM East Coast USA Time

• 91 - AI-DRIVEN DISCOVERY OF TWO-GENE BLOOD TEST FOR THE DIAGNOSIS OF KAWASAKI DISEASE USING A CAP ACCREDITED CLIA CERTIFIED QPCR PLATFORM

  Monday, August 26, 2024
  3:15 PM – 4:00 PM East Coast USA Time